If you missed out on CDx Europe, Click the image below to explore our 2nd Liquid Biopsy Surveillance & Early Detection Summit

Enabling Precision Medicine in Oncology, CNS & NASH to Power Advanced, Affordable Diagnostics for All

April 26-27, 2023 | London, UK

Accelerating Biomarker-Driven Drugs into Clinical Trials Whilst Strategising Your CDx Development, IVDR Compliance & Commercialisation Path to Improve Clinical Decision Making & Patient Outcomes

The 13th Clinical Biomarkers & CDx Europe 2023 returned as the premier European forum for end-to-end discussions, actionable insights and partnership development to guide biomarker discovery and companion diagnostics (CDx) development programmes as they progress towards commercialisation.

With two dedicated tracks on Biomarker Development and Drug-Dx Development & Commercialisation, this summit was the ultimate guide to:


Understand European Biomarkers & CDx Development advancements in multiple disease areas in oncology and non-oncology indications


Discuss emerging functional assays and software technologies to advance and accelerate clinical and research programs aimed at personalising care for patients


Stay up to date with European specific regulatory, commercialisation and market access challenges and processes to successfully create your end-to-end biomarker & CDx strategy


Join forces to define a better framework for reimbursement of biomarkers that enable an equitable access to them for patients


250+ Clinical Biomarkers, Translational Medicine, Precision Medicine & Companion Diagnostics Directors, Heads and VPs came together with biomarker and CDx solution providers, regulatory experts and notified bodies for a well-rounded, unmissable all-stakeholders included learning and networking experience.

Our 2023 Expert Speaker Faculty Included:

2023 Partners

Other Events in the Series